In 2020, in Europe, there were
58,169 cervical cancer cases
and 25,989 deaths.

Incidence and mortality rates vary widely across
Europe, with age-standardized incidence rates
ranging from less than 5 cases per 100,000 women
to above 25 cases per 100,000 women and
age-standardised mortality rates from 1
death per 100,000 women to 10
deaths per 100,000 women.
HPV vaccination coverages vary
considerably across Europe
Cervical cancer can be prevented by the HPV
vaccination, however HPV vaccination coverages
vary considerably across Europe from less
than 5% to more than 90%.
18 European countries and 34
partner organisations working
together to increase HPV vaccination coverage
specially in regions with low coverage and to
optimize data collection to monitor HPV vaccination
coverage and the impact of vaccination.



In 2020, in Europe, there were
58,169 cervical cancer cases
and 25,989 deaths.

Incidence and mortality rates vary widely across
Europe, with age-standardized incidence rates
ranging from less than 5 cases per 100,000 women
to above 25 cases per 100,000 women and
age-standardised mortality rates from 1
death per 100,000 women to 10
deaths per 100,000 women.
HPV vaccination coverages vary
considerably across Europe
Cervical cancer can be prevented by the HPV
vaccination, however HPV vaccination coverages
vary considerably across Europe from less
than 5% to more than 90%.
18 European countries and 34
partner organisations working
together to increase HPV vaccination coverage
specially in regions with low coverage and to
optimize data collection to monitor HPV vaccination
coverage and the impact of vaccination.

About PERCH

PERCH Kick – OFF Meeting – December 2022 – Brussels

Project PERCH brings together 18 European countries and 34 partner organizations with the objective of contributing to the implementation of Europe’s Beating Cancer Plan. PERCH aligns with the World Health Organization’s (WHO) “90-70-90” strategy, aiming to achieve at least 90% HPV vaccination coverage among girls, and potentially boys, by the age of 15 years.

Project objectives are:

  • Improve capacities of Member States to plan and implement HPV vaccination campaigns by sharing knowledge and experience.
  • Improve data and monitoring system on HPV vaccination and HPV screening.
  • Improve knowledge and awareness on HPV-related disease and prevention in specific target groups (adolescent girls and boys).
  • Improve knowledge and abilities for healthcare professionals in HPV vaccine communication.

SOCIAL MEDIA

Newsletter subscrition

Subscribe to PERCH newsletter and get the latest updates from European Partnership to Contrast HPV

NEWS

Editorial article “Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer” published in the JNCI: Journal of the National Cancer Institute

Recently an editorial article “Linkage of individual-patient data confirms protection of prophylactic human papillomavirus vaccination against invasive cervical cancer,” was published in the “JNCI: Journal of the National Cancer Institute”. It has provided an overview of the excellent effectiveness of the human papillomavirus (HPV) vaccine in preventing invasive cervical cancer,

Read More »
NEWS

Project PERCH Presentation at EUROGIN 2024

At this year’s EUROGIN Congress in Stockholm, the project was presented by experts involved in the project on Saturday, March 16th in the scientific sessions, chaired by esteemed expert Marc Arbyn and Raffaella Bucciardini, the coordinator of the project. Raffaella Bucciardini from Instituto Superiore di Sanita, Italy had the opening

Read More »
NEWS

HPV Awareness Day

4th March is HPV Awareness Day. HPV can cause serious diseases like cervical and penile, vaginal, vulvar, anal, and throat cancer. Most HPV cancers can be prevented by HPV vaccination, which remains one of the most powerful and efficient public health measures. Organisations around the world mark this day day

Read More »
EVENTS

PERCH WP2 meeting

The PERCH WP2 meeting produced valuable results On 24 and 25 April 2024, health and communication experts from the PERCH partner countries met in person in Ljubljana and via Zoom. The main purpose of the PERCH WP2 meeting was to facilitate discussions and collaboration between the participating countries on the

Read More »

Newsletter subscrition

Subscribe to PERCH newsletter and get the latest updates from European Partnership to Contrast HPV

Skip to content